Target Audience
This virtual meeting will be of interest to consultant
pharmacists who work with geriatric patients. Focusing
on the results of formal studies and the use of case studies,
this audioconference will assist pharmacists and nurses
in understanding the causes of psychosis in the elderly
and the latest information regarding safe and effective
therapeutic strategies for this population of the elderly.
Learning
Objectives
On completion of this audioconference, the participant
should be able to: |
|
|
List the
common patterns of behavioral symptoms in the elderly
with dementia. |
|
|
Describe
the usual clinical approach to evaluation and non-pharmacologic
management of psychotic symptoms in this population.
|
|
|
Discuss
current information regarding the safety, tolerability
and efficacy of antipsychotics used to treatment these
symptoms. |
| Program
Outline |
|
I.
|
Case Study |
|
II.
|
Causes of
Psychosis in the Elderly |
|
III.
|
General
Approaches |
|
IV.
|
Nonpharmacological
Approaches |
|
V.
|
Conventional
Antipsychotics |
|
VI.
|
Atypical
Antipsychotics |
|
VII.
|
Future Studies
|
Faculty
Pierre N. Tariot, MD |
|
|
Professor
of Psychiatry, Medicine and Neurology
University of Rochester Medical Center
Director of Psychiatry and Neurobehavioral Therapeutics
Monroe Community Hospital
Rochester, New York |
|
Melody
Ryan, PharmD
|
|
|
Assistant
Professor
Division of Pharmacy Practice and Science
University of Kentucky College of Pharmacy and Department
of Neurology
University of Kentucky College of Medicine
Lexington, Kentucky |
Pierre N. Tariot, MD serves
as Chairman of the Medical Advisory Committee for the
Rochester Chapter of the Alzheimer’s Association
and on the Geriatric Health Advisory Board of a Rochester
HMO. His research interests include characterization and
treatment of psychopathology of dementia, clinical and
basic approaches to neuroprotection, definition of the
use of cholinergic therapies, and nursing home studies.
He has served as principal investigator on numerous clinical
research studies and has lectured and published extensively
on geriatric psychiatry. He currently also serves as a
reviewer for several leading medical journals and study
committees.
Melody Ryan, Pharm D has
lectured and published extensively on the pharmacological
treatment of neurological disorders, including parkinsonism
and psychosis, and geriatric pharmacy and is an active
member of several leading pharmacy professional organizations.
She currently serves as an ad hoc reviewer for several
leading pharmacy journals and has served as co-investigator
in numerous clinical trials.
Disclosure
Dr. Tariot reports receiving grants, honoraria, and consulting
fees from Pfizer, Novartis, Eli Lilly, Janssen, Eisai,
Bristol-Myers Squibb, AstraZeneca.
Dr. Ryan reports receiving
honoraria from AstraZeneca.
 |
This
program, ACPE#: 203-999-01-307-H01, was developed
by the American Society of Consultant Pharmacists
(ASCP) and is approved for 1.0 Contact Hour (0.1 CEU).
ASCP is approved by the American Council on Pharmaceutical
Education (ACPE) as a provider of continuing pharmaceutical
education. Program Date: November 2001. This program
is valid through February 2003. |
This program was developed
by Medical Communications Media, Inc. in conjunction with
ASCP and supported by an unrestricted grant from AstraZeneca.
Instructions
- The first program screen
will permit you to check for or download RealAudio's
RealPlayer required to run this program.
- Clicking on "start
the program" on the next screen will begin the
program.
- Instructions for viewing
the program and completing a CE post-test and evaluation
will be found on the program’s opening screen.
The program will require approximately one hour to complete.
- A minimum score of 70%
on the post-test is required for a CME or CE certificate.
Certificate Fee: $0
